About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Ohio | 435 Studies

Clinical Trials Ovarian CancerOhio

Ovarian Cancer Clinical Trials in Ohio

Find 435 clinical trials for ovarian cancer near Ohio. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 435 trials

CompletedPhase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary CancerPhase II single arm, open label, nonrandomized study.NCT02766582·Cleveland, Ohio and 1 other Active not recruitingTesting the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal CancerThis phase II trial studies how well olaparib with or without tremelimumab works in treating patients with ovarian, fallopian tube, or peritoneal cancer that has come back…NCT04034927·Orange, California and 19 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial CancersThis is a two-part study consisting of Part A (dose regimen finding) followed by Part B (dose expansion).NCT03138408·Birmingham, Alabama and 11 others

CompletedTopotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryRATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00842452·Cleveland, Ohio

CompletedPaclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003518·Denver, Colorado and 18 others

RecruitingA Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer.NCT06161025·Anchorage, Alaska and 163 others

CompletedTLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian CancerThe purpose of this study is to demonstrate superiority in survival in favor of TLK286 as compared to active control therapy with Doxil/Caelyx or Hycamtin in the intent-to-treat…NCT00057720·Little Rock, Arkansas and 319 others

TerminatedCombination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003378·Birmingham, Alabama and 63 others

CompletedFractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer SurvivorsThis randomized pilot trial studies how well fractional carbon dioxide (CO2) laser therapy works in minimizing genitourinary syndrome of menopause (GSM) in gynecological cancer…NCT03372720·Baltimore, Maryland and 3 others

Active not recruitingPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerThis phase II/III trial studies how well pegylated liposomal doxorubicin hydrochloride with atezolizumab and/or bevacizumab work in treating patients with ovarian, fallopian tube…NCT02839707·Anchorage, Alaska and 918 others

TerminatedA Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsThis is a Phase 1b/2, open-label, multicenter study of DSP-7888 Dosing Emulsion in combination with checkpoint inhibitors (nivolumab or pembrolizumab) in adult patients with solid…NCT03311334·Tucson, Arizona and 18 others

CompletedGefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: Biological therapies such as gefitinib may interfere with the growth of the tumor cells and may slow the growth of ovarian epithelial cancer or primary peritoneal…NCT00023699·Birmingham, Alabama and 52 others

CompletedA Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)A Phase 3 global study comparing avelumab alone to avelumab plus PLD and to PLD alone to demonstrate that avelumab given alone or in combination with PLD is superior to PLD alone…NCT02580058·Chandler, Arizona and 294 others

CompletedGemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00227721·Dearborn, Michigan and 3 others

TerminatedA Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline VariantsThe objective of this project is to validate the sensitivity, specificity, positive predictive value and negative predictive values of the AMRA blood test for assessing risk of…NCT04487405·Chandler, Arizona and 8 others

TerminatedChemoFx® PRO - A Post-Market Data Collection StudyThis study will collect patient demographic, oncology history, and physician reported outcome information following the initial round of chemotherapy received after a commercial…NCT00669422·Birmingham, Alabama and 66 others

CompletedPemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00087087·Hinsdale, Illinois and 34 others

UnknownCirculating Tumor DNA Exposure in Peripheral BloodThis is a prospective, multi-center, blinded feasibility study.NCT03517332·Tucson, Arizona and 5 others

CompletedEfficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 LevelsThe purpose of this study is to determine whether injections of Å6 are effective in treating ovarian cancer patients who have completed first-line therapy and currently have no…NCT00083928·Birmingham, Alabama and 23 others

CompletedZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian CancerThe purpose of this study is to evaluate whether treatment with a new drug called ZK-Epothilone (ZK-Epo) given with carboplatin in patients with recurrent ovarian cancer, who…NCT00325351·Tucson, Arizona and 15 others

PreviousPage 10 of 22Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia